Faculty Scholars

Bryan Miller

Bryan Miller, Ph.D.

Associate Professor/Graduate Coordinator
Department of Sociology, Anthropology and Criminal Justice

College of Behavioral, Social and Health Sciences

Contact: blm2@clemson.edu

Who is Dr. Miller?

Bryan Lee Miller is an associate professor in the Department of Sociology, Anthropology and Criminal Justice. He teaches and conducts research on drugs and crime, corrections, and criminology. His work has evaluated drug abuse, offender reentry, and drug treatment. His recent research has focused on evaluating the use of novel psychoactive drugs among those in community corrections. He is currently working on projects funded by the United States Department of Justice to improve police response to individuals in mental health crises, reduce the number of individuals with mental illnesses and co-occurring disorders in jail, and to evaluate veteran treatment courts. He has authored over 50 peer-reviewed articles as well as the bookEmerging Trends in Drug Use and Distribution(2014, Springer). He is an associate editor of theAmerican Journal of Criminal Justice and serves on the editorial board forCorrections: Policy, Practice and Research. He is Chair of the Drug and Alcohol Research Section of the Academy of Criminal Justice Sciences and will serve as the 49th President of the Southern Criminal Justice Association. He was a 2018-2019 Fulbright Scholar and conducted research on emerging drugs, cryptomarkets, and the influence of social media at Tampere University, Finland.

For more information, see his Department Profile.

How Dr. Miller’s research is transforming health care

Dr. Miller is currently working on a Bureau of Justice Assistance funded initiative with the Clemson University Police Department to partner with campus and community behavioral health services to improve law enforcement responses to individuals in mental health crises.

News and media related to Dr. Miller’s research

Health Research Expertise Keywords

Drugs and crime, Drug use and abuse, Drug treatment, Synthetic psychoactive drugs, Mental health